Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. (Q38310198)
Jump to navigation
Jump to search
scientific article published on June 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. |
scientific article published on June 2000 |
Statements
1 reference
Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. (English)
1 reference
M Ishii
1 reference
M Iwahana
1 reference
I Mitsui
1 reference
M Minami
1 reference
S Imagawa
1 reference
A Tohgo
1 reference
A Ejima
1 reference
1 June 2000
1 reference
1 reference
11
1 reference
5
1 reference
353-362
1 reference
Identifiers
1 reference
1 reference